CASE REPORT: Neuroleptic malignant syndrome following reintroduction of an antipsychotic after overdose

Korchia, Théo
Blackman, Graham
Cermolacce, Michel
Richieri, Raphaëlle

¹Department of Psychiatry, Assistance Publique Hopitaux de Marseille, Marseille, France,
²Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK,
³Institut Fresnel - UMR 7249, Faculté des Sciences de Saint Jérôme, Marseille, France,

Correspondence to Dr Raphaëlle Richieri, e-mail; [email protected]

/Accepted July 14, 2018

Contributors TK, MC: contributed to the acquisition or interpretation of data. TK, GB, MC, RR: drafted the work or revised it critically for important intellectual content. TK, GB, MC, RR: read the final version of this manuscript, approve its content and submission for publication. TK, GB, MC, RR: agreed to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

Competing interests None declared.

Patient consent Obtained.

Provenance and peer review Not commissioned; externally peer reviewed.

BMJ Case Reports :p 223922, January 2018. | DOI: 10.1136/bcr-2017-223922

Neuroleptic malignant syndrome (NMS) is a potentially lethal adverse drug reaction. We report a case of NMS potentially induced by dehydration in a female patient suffering from schizoaffective disorder. We discuss possible aetiologies and triggering factors alongside the existing literature.